NYSE:MCKMcKesson Stock Price, Forecast & News

McKesson's stock was trading at $135.17 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, MCK shares have increased by 18.3% and is now trading at $159.90.
View which stocks have been most impacted by Coronavirus.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 5 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for McKesson.

McKesson is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020.
View our earnings forecast for McKesson.

McKesson Co. (NYSE:MCK) announced its earnings results on Monday, August, 3rd. The company reported $2.77 EPS for the quarter, topping analysts' consensus estimates of $2.27 by $0.50. The company earned $55.68 billion during the quarter, compared to analysts' expectations of $54.16 billion. McKesson had a net margin of 0.39% and a return on equity of 41.07%. The company's revenue for the quarter was down .1% compared to the same quarter last year. During the same quarter last year, the firm posted $3.31 EPS.
View McKesson's earnings history.

McKesson declared a quarterly dividend on Wednesday, July 29th. Shareholders of record on Tuesday, September 1st will be paid a dividend of $0.42 per share on Thursday, October 1st. This represents a $1.68 dividend on an annualized basis and a dividend yield of 1.05%. The ex-dividend date is Monday, August 31st. This is a positive change from McKesson's previous quarterly dividend of $0.41.
View McKesson's dividend history.

McKesson issued an update on its FY21 earnings guidance on Monday, August, 3rd. The company provided earnings per share (EPS) guidance of $14.70-15.50 for the period, compared to the Thomson Reuters consensus estimate of $14.39.

14 brokers have issued 1-year price targets for McKesson's stock. Their forecasts range from $146.00 to $197.00. On average, they anticipate McKesson's share price to reach $173.69 in the next year. This suggests a possible upside of 8.6% from the stock's current price.
View analysts' price targets for McKesson.

News stories about MCK stock have trended negative this week, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. McKesson earned a news sentiment score of -2.9 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the immediate future.
View the latest news about McKesson.

McKesson saw a decline in short interest in the month of July. As of July 15th, there was short interest totaling 2,420,000 shares, a decline of 5.1% from the June 30th total of 2,550,000 shares. Based on an average daily trading volume, of 1,380,000 shares, the short-interest ratio is presently 1.8 days. Currently, 1.5% of the company's shares are sold short.
View McKesson's Current Options Chain.

Some companies that are related to McKesson include AmerisourceBergen (ABC), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO) and Owens & Minor (OMI).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other McKesson investors own include Walt Disney (DIS), Gilead Sciences (GILD), CVS Health (CVS), salesforce.com (CRM), UnitedHealth Group (UNH), Johnson & Johnson (JNJ), Allergan (AGN), Bank of America (BAC), AbbVie (ABBV) and Chevron (CVX).

McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

McKesson's stock is owned by a variety of retail and institutional investors. Top institutional investors include Pzena Investment Management LLC (1.85%), Scharf Investments LLC (0.55%), Sumitomo Mitsui Trust Holdings Inc. (0.45%), Strs Ohio (0.24%), Robeco Institutional Asset Management B.V. (0.20%) and UBS Group AG (0.20%). Company insiders that own McKesson stock include Brian S Tyler, Brian Scott Tyler, Britt J Vitalone, Lori A Schechter, M Christine Jacobs, N Anthony Coles and Sundeep G Reddy.
View institutional ownership trends for McKesson.

MCK stock was sold by a variety of institutional investors in the last quarter, including Prudential PLC, Pzena Investment Management LLC, Morningstar Investment Services LLC, MERIAN GLOBAL INVESTORS UK Ltd, SG Americas Securities LLC, Wedge Capital Management L L P NC, First Trust Advisors LP, and Raymond James & Associates. Company insiders that have sold McKesson company stock in the last year include Brian S Tyler, Britt J Vitalone, Lori A Schechter, M Christine Jacobs, and Sundeep G Reddy.
View insider buying and selling activity for McKesson.

MCK stock was purchased by a variety of institutional investors in the last quarter, including UBS Group AG, Mackay Shields LLC, Strs Ohio, Assenagon Asset Management S.A., State of Alaska Department of Revenue, Raymond James Financial Services Advisors Inc., Railway Pension Investments Ltd, and Sumitomo Mitsui Trust Holdings Inc..
View insider buying and selling activity for McKesson.

Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of MCK stock can currently be purchased for approximately $159.90.

McKesson has a market capitalization of $25.92 billion and generates $231.05 billion in revenue each year. The company earns $900 million in net income (profit) each year or $14.95 on an earnings per share basis. McKesson employs 80,000 workers across the globe.

The official website for McKesson is www.mckesson.com.

McKesson's mailing address is 6555 STATE HWY 161, IRVING TX, 75039. The company can be reached via phone at 972-446-4800 or via email at [email protected]